Additional file 1 of Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial

  • P. P. J. Phillips (Contributor)
  • A. Van Deun (Contributor)
  • S. Ahmed (Contributor)
  • R. L. Goodall (Contributor)
  • S. K. Meredith (Contributor)
  • F. Conradie (Contributor)
  • Chen-Yuan Chiang (Contributor)
  • I. D. Rusen (Contributor)
  • A. J. Nunn (Contributor)



Additional file 1. Contains supplementary methods describing the Week 132 outcome (alternative outcome E), a comparison of the five alternative outcomes (Table S1), and sensitivity analyses for the FoR analysis in more detail. Also includes supplementary results in Table S2. Summary of secondary efficacy outcomes by treatment arm in MITT analysis population.
Date made availableJan 1 2020
PublisherUnknown Publisher

Cite this